AlphAIAlphAI — Financial news for AI agents
benzinga.com$INLF

INLIF Stock Jumps 93% After Hours - INLIF (NASDAQ:INLF)

INLIF Limited (NASDAQ:INLF) shares surged 93.22% to $5.70 in after-hours trading on Thursday after reporting a 26.01% net revenue rise in its unaudited first-half fiscal 2026 results. Net revenue reached $12.94 million, gross profit increased 158.77% to $4.65 million, and net income turned positive at $1.01 million. The company also announced a 1-for-200 reverse stock split. According to Benzinga Pro, the stock closed at $2.95 during regular trading, up 1.37%.

Original reporting
benzinga.com
Published Sep 25, 2026, 3:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 4:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$INLF
Bullish
high confidence
Mentioned
$INLF
Relevance
6/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$INLFBullishHigh
01

Why it matters

Earnings beat and cash buildup suggest operational improvement, but small market cap implies high volatility.

02

Market read

Micro‑cap earnings surprise with large after‑hours move; relevant for short‑term traders.

03

What to watch

Reverse stock split could attract new investors but also signal compliance pressure.

Relevance 6/10Novelty 7/10Timing: after‑hours Thursday

Background

INLIF is a China‑based manufacturer of manipulator arms listed on NASDAQ.

Company-level read

Ticker impact

$INLFBullishHigh confidence
Context

INLIF reported unaudited H1 2026 results with revenue up 26% and a 93% after‑hours price jump.

Expected impact

Potential continuation if momentum holds; watch for profit‑taking near $5‑6.

Evidence & confidence

Revenue and profit growth exceed prior year, and cash balance rose sharply, supporting upside bias.

Market effects

Sector

Positive signal for niche manipulator‑arm manufacturers and related industrial robotics.

Regional

Limited to micro‑cap segment; minimal broader market effect.

Global

Low; impact confined to specialized industrial equipment niche.

Counterpoint

What could challenge this read

Rapid price rise may be unsustainable for a micro‑cap; risk of volatility and liquidity constraints.

Key entities

  • Executive
    Rongjun Xu

    CEO who attributed turnaround to expanded customer base and new intelligent equipment business.

Read at source← All news

Related articles

$INLFMed

INLIF Ltd (INLF): Financial results for H1 2026

INLIF Ltd (INLF) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 INLIF LIMITED Reports First Half of Fiscal Year 2026 Financial Results Quanzhou, China, September 24, 2026 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the

SEC EDGAR 6-K
$INLFMedAI 8/10

INLIF LIMITED Accelerates Strategic Layout in New Energy Sector, Securing $4.4 Million First Order for Battery Cell Packing Machines

INLIF Limited (NASDAQ: INLF) said it confirmed commercial delivery of its first battery cell packing machines order, worth nearly RMB 30 million (about US$4.4 million). The contract includes 14 units for a domestic battery manufacturer; the customer also placed a follow-on order for six more units. INLIF estimates up to 50 units by end-2026 (about RMB 100 million+), subject to demand and execution risks.

manilatimes.net
$AVLNMed

Avalyn Reports Third Quarter 2026 Financial Results and Recent

Avalyn Pharma Inc. (AVLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights Initiated Phase 1 study of AP03, a fixed dose combination of nebulized pirfenidone and nintedanib, in healthy volunteers Presented new AP01 data at ERS Congress and published detailed results from

SEC EDGAR 8-K
$MGTXHigh

MeiraGTx Reports Third Quarter 2026 Financial and Operational Results

MeiraGTx Holdings plc (MGTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MeiraGTx Reports Third Quarter 2026 Financial and Operational Results ● Submission of Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP)

SEC EDGAR 8-K
$VOXRMed

VOX ROYALTY CORP. (VOXR): Financial results for Q3 2026

VOX ROYALTY CORP. (VOXR) furnished an SEC Form 6-K — earnings release. EXHIBIT 99.5 VOX ROYALTY REPORTS Q3 2026 RESULTS AND DECLARES QUARTERLY DIVIDEND DENVER – November 11, 2026 – Vox Royalty Corp. (NASDAQ: VOXR ) (TSX: VOXR ) (“ Vox ” or the “ Company ”), a returns-focused mining royalty and streaming company, is pleased to announce its operating

SEC EDGAR 6-K
$LUCDMed

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results

Lucid Diagnostics Inc. (LUCD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results EsoGuard ® now fully reimbursed by Medicare nationwide, launching a new phase of accelerating commercialization with record monthly test volume to start the fourth quarter Con

SEC EDGAR 8-K